Hook & thesis
ASML is not a victim of a supply bottleneck — it is the bottleneck. Orders for its extreme ultraviolet (EUV) lithography systems extend into 2029-2030, and management has signaled capacity will constrain revenue growth in the near-term even as it scales output. That creates a rare combination for toolmakers: sustained pricing power, a multi-year backlog and high visibility into future install-based revenue.
We view the recent pullback into the $1,500s as a tactical buying opportunity. The market is wrestling with macro noise and technical momentum (RSI ~38, MACD negative), but the fundamental driver remains intact: AI-driven demand for advanced nodes keeps fabs hungry for ASML's most complex systems. Our trade plan is a disciplined long with a clear stop and a 180-trading-day horizon aligned with delivery cadence and capacity expansions.
What ASML does and why it matters
ASML Holding NV builds the machines that make the most advanced semiconductor chips. Its product mix centers on lithography, metrology and inspection systems, with EUV lithography the critical tool for sub-7nm node production. Because EUV capacity is scarce and capital-intensive, ASML's customers - leading foundries and integrated device manufacturers - place multiyear orders and accept multi-year delivery schedules. That structural demand dynamic is the core of the thesis: when demand outstrips supply at the equipment level, vendors capture disproportionate benefit in revenue, margins and order book pricing.
Facts and figures that support the case
- Market capitalization stands at roughly $619.1 billion, making ASML one of the largest semiconductor-equipment names globally.
- Q3 revenue grew 55% to €11.66 billion, per recent company commentary, driven by EUV system sales into AI data-center builds - a clear sign of demand strength.
- Management plans a ~30% capacity increase in 2027, yet customer orders remain visible into 2029-2030, implying supply will still be constrained even after the expansion.
- The stock trades near $1,599 today, well below its 52-week high of $1,999.96 and well above its 52-week low of $946.11, reflecting both cyclical breadth and long-term secular growth.
- Valuation sits at a trailing PE of ~38.7 and a PB of ~24.2, above broad-market averages but not outlandish for a near-monopoly provider of critical equipment.
Why the market should care right now
Three converging forces make ASML a high-impact trade: (1) the AI-driven restart of fab capex that prioritizes advanced nodes and HBM, (2) ASML's tight installation cadence that gives it pricing leverage and backlog visibility, and (3) near-term technical weakness that presents an entry point after a meaningful run-up earlier in the year. The company also pays a quarterly dividend of $1.791518 with ex-dividend date 10/27/2026 and payable date 11/04/2026 - a modest income kicker for longer-horizon holders.
Valuation framing
At roughly $619 billion market cap and a PE around 38.7x, ASML is priced for strong, durable growth but not immune to multiple compression if sentiment sours. Importantly, ASML's forward multiple (management and analysts point to a 27x forward in recent commentary) is below its five-year average of ~33x, suggesting the market has already partially re-rated the name from peak multiples earlier in the cycle. Given the company's effective oligopoly on EUV and the multi-year order book, a premium relative to industrial peers is warranted; the key question is how much of future earnings are already priced into $1,600 per share.
Trade plan (entry, stop, target and horizon)
| Item | Value |
|---|---|
| Entry price | $1,599.00 |
| Stop loss | $1,460.00 |
| Target price | $1,999.96 |
| Time horizon | Long term (180 trading days) - aligns with delivery cadence and expected contribution from 2027 capacity increases |
Rationale: this is not a quick mean-reversion scalp. The 180-trading-day horizon gives time for additional deliveries, quarter-to-quarter revenue recognition and for the market to re-rate the company as backlog converts to revenue. The stop at $1,460 is below recent intraday support and provides room for near-term volatility while limiting downside if orders or execution disappoint.
Catalysts to watch (2-5)
- Quarterly reports showing continued strong EUV shipments and revenue recognition (past Q3 growth of 55% to €11.66 billion sets a high bar) - beats would validate the thesis.
- Progress on the announced 30% capacity increase in 2027 - updates confirming on-time, on-budget expansion would support multiple expansion.
- Geopolitical developments or export-control clarifications that either open or constrain markets (China access would materially affect future backlog composition).
- Industry capex cadence from major customers (TSMC, Samsung, Intel) and HBM demand signals from AI cloud players - sustained capex accelerates ASML revenue conversion.
Risks (balanced and specific)
- Execution risk on capacity expansion - a planned 30% increase in 2027 is meaningful, but delays or cost overruns would keep supply tight and could damage credibility, potentially pressuring the share price.
- Geopolitical and export controls - restrictions, particularly related to China, could reduce addressable market or shift customer mixes, shortening visibility into the backlog.
- Customer concentration - a handful of large foundries account for a substantial portion of demand; any pause or shift in their capex plans would materially impact ASML's near-term results.
- Cyclicality and oversupply risk out to 2029 - while demand currently outpaces supply, analyst projections already flag potential oversupply by 2029; if fab builds slow materially, equipment demand could roll over.
- Valuation vulnerability - trading at elevated multiples, ASML can see big price swings if growth disappoints or if macro risk premiums rise.
Counterargument: If fab capex decelerates faster than current orders indicate - for example driven by an economic slowdown, AI hardware optimization that reduces wafer starts, or meaningful customer cancellations - ASML's backlog may not convert at the current pace. That outcome could lead to inventory and revenue misses and cause significant multiple contraction from current levels.
What would change my mind
I will reconsider the long stance if any of the following occur: (1) management announces meaningful cancellations or steep pushes of booked deliveries beyond 2029, (2) the 2027 capacity expansion shows large slippage that materially reduces 2027-2028 revenue visibility, or (3) macro indicators and major customer capex plans turn decisively negative, signaling a structural pause in AI-driven fab builds. Conversely, tangible acceleration in EUV shipments or clearer visibility into incremental capacity beyond 2027 would strengthen the bullish case.
Conclusion and practical take
ASML presents a tactical long: it is a structurally advantaged supplier to the AI-era semiconductor build-out with a multiyear backlog and pricing power. The pullback into the $1,500s presents an entry where downside can be capped with a tight stop and upside captured as backlog converts to revenue over the next 180 trading days. This is not a no-risk trade; execution, geopolitics and cyclicality are real risks that could flip the thesis. For disciplined investors who accept those risks, the trade offers asymmetric potential: limited, defined downside with multi-hundred-dollar upside if deliveries and capacity moves play out as planned.
Key monitoring checklist for the trade
- Next quarterly results: EUV shipment volume and system revenue vs guidance.
- Updates on 2027 capacity expansion timing and incremental capital expenditures.
- Customer capex commentary from TSMC, Samsung, Intel and major cloud providers.
- Any official export-control developments affecting equipment sales into China or other regions.
Trade with position sizing that limits account-level risk to a tolerance you’re comfortable with; this is a medium-risk, event-driven long that benefits from patient capital and clear guardrails.